ArticleAnnals of medicine2025
A nomogram model for predicting maternal cardiovascular complications and neonatal adverse outcomes in pregnant patients with pulmonary arterial hypertension.
Article in Annals of medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The preoperative risks of pulmonary hypertension crisis for the cesarean puerpera with pulmonary artery hypertension.BMC pregnancy and childbirth · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPulmonary arterial hypertension (PAH) during pregnancy significantly increases maternal and fetal mortality risk. We developed nomogram prediction models from retrospective data to assess maternal cardiovascular risks and neonatal adverse outcomes.
methodsOur study included 170 pregnant women, divided into training (70%) and validation (30%) sets. Predictors of outcomes were identified using logistic regression in the training set, and nomograms were constructed to predict maternal cardiovascular complications and neonatal adverse outcomes. Model performance was evaluated through internal validation.
resultsPredictors of cardiovascular complications included severe PAH (OR = 4.80), New York Heart Association (NYHA) classification ≥ III (OR = 25.94), ST-T changes (OR = 25.18), total bilirubin (OR = 1.49), albumin (OR = 0.87) and lactate dehydrogenase level (OR = 1.01). The nomogram showed high predictive accuracy with concordance indices of 0.96 and 0.91, areas under the ROC curve of 0.96 and 0.93. Neonatal outcome predictors included gestational age at termination (OR: 0.93), maternal platelet count level (OR: 0.99), and B-type natriuretic peptide level (OR: 1.00). The corresponding nomogram showed concordance indices in the training set and validation set were 0.92 and 0.73, respectively, with area under the ROC curve values of 0.92 and 0.73.
conclusionsNomogram models based on the above factors useful tools for predicting cardiovascular complications and neonatal adverse outcomes in pregnant women with PAH, potentially aiding in early detection and timely intervention. Further validation is needed to confirm their accuracy in broader clinical settings.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.